11.85 USD
+0.17 (+1.46%)
11.6 USD
-0.25 (-2.11%)
Taking everything into account, TNGX scores 4 out of 10 in our fundamental rating. TNGX was compared to 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for TNGX as it has an excellent financial health rating, but there are worries on the profitability. TNGX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year TNGX has reported negative net income.
- In the past year TNGX has reported a negative cash flow from operations.
- TNGX had negative earnings in each of the past 5 years.
- TNGX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -47.83%, TNGX perfoms like the industry average, outperforming 53.14% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -62.81%, TNGX is in line with its industry, outperforming 59.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.83% | ||
| ROE | -62.81% | ||
| ROIC | N/A |
ROA(3y)-30.42%
ROA(5y)-20.6%
ROE(3y)-49.57%
ROE(5y)-33.14%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for TNGX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- TNGX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, TNGX has more shares outstanding
- There is no outstanding debt for TNGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 14.75 indicates that TNGX is not in any danger for bankruptcy at the moment.
- TNGX has a better Altman-Z score (14.75) than 85.52% of its industry peers.
- There is no outstanding debt for TNGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 14.75 |
ROIC/WACCN/A
WACC8.86%
2.3 Liquidity
- A Current Ratio of 8.88 indicates that TNGX has no problem at all paying its short term obligations.
- TNGX's Current ratio of 8.88 is fine compared to the rest of the industry. TNGX outperforms 78.10% of its industry peers.
- A Quick Ratio of 8.88 indicates that TNGX has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 8.88, TNGX is in the better half of the industry, outperforming 78.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.88 | ||
| Quick Ratio | 8.88 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 22.03% over the past year.
- The Revenue has grown by 53.28% in the past year. This is a very strong growth!
- The Revenue has been growing slightly by 4.34% on average over the past years.
EPS 1Y (TTM)22.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%151.85%
Revenue 1Y (TTM)53.28%
Revenue growth 3Y4.34%
Revenue growth 5YN/A
Sales Q2Q%363.61%
3.2 Future
- Based on estimates for the next years, TNGX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.03% on average per year.
- TNGX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.53% yearly.
EPS Next Y24.88%
EPS Next 2Y-1.64%
EPS Next 3Y-5.73%
EPS Next 5Y9.03%
Revenue Next Year37.77%
Revenue Next 2Y-50.45%
Revenue Next 3Y-30.53%
Revenue Next 5Y39.53%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TNGX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNGX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as TNGX's earnings are expected to decrease with -5.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.64%
EPS Next 3Y-5.73%
5. Dividend
5.1 Amount
- TNGX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TANGO THERAPEUTICS INC / TNGX FAQ
What is the ChartMill fundamental rating of TANGO THERAPEUTICS INC (TNGX) stock?
ChartMill assigns a fundamental rating of 4 / 10 to TNGX.
What is the valuation status of TANGO THERAPEUTICS INC (TNGX) stock?
ChartMill assigns a valuation rating of 0 / 10 to TANGO THERAPEUTICS INC (TNGX). This can be considered as Overvalued.
What is the profitability of TNGX stock?
TANGO THERAPEUTICS INC (TNGX) has a profitability rating of 1 / 10.